405 related articles for article (PubMed ID: 36297672)
1. Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges.
Du R; Wang C; Zhu L; Yang Y
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297672
[TBL] [Abstract][Full Text] [Related]
2. Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing.
Duan L; Ouyang K; Wang J; Xu L; Xu X; Wen C; Xie Y; Liang Y; Xia J
Chembiochem; 2021 Dec; 22(24):3360-3368. PubMed ID: 34418266
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles.
Jurgielewicz B; Stice S; Yao Y
Aging Dis; 2021 Sep; 12(6):1476-1493. PubMed ID: 34527423
[TBL] [Abstract][Full Text] [Related]
4. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer.
Godbole N; Quinn A; Carrion F; Pelosi E; Salomon C
Semin Cancer Biol; 2023 Nov; 96():64-81. PubMed ID: 37820858
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy.
Jiang L; Vader P; Schiffelers RM
Gene Ther; 2017 Mar; 24(3):157-166. PubMed ID: 28140387
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles: powerful candidates in nano-drug delivery systems.
Liu X; Cao Y; Wang S; Liu J; Hao H
Drug Deliv Transl Res; 2024 Feb; 14(2):295-311. PubMed ID: 37581742
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle-Based Nucleic Acid Delivery: Current
Massaro C; Sgueglia G; Frattolillo V; Baglio SR; Altucci L; Dell'Aversana C
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33081417
[TBL] [Abstract][Full Text] [Related]
11. Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines.
Kuriyama N; Yoshioka Y; Kikuchi S; Okamura A; Azuma N; Ochiya T
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885247
[TBL] [Abstract][Full Text] [Related]
12. Engineered Cas9 extracellular vesicles as a novel gene editing tool.
Osteikoetxea X; Silva A; Lázaro-Ibáñez E; Salmond N; Shatnyeva O; Stein J; Schick J; Wren S; Lindgren J; Firth M; Madsen A; Mayr LM; Overman R; Davies R; Dekker N
J Extracell Vesicles; 2022 May; 11(5):e12225. PubMed ID: 35585651
[TBL] [Abstract][Full Text] [Related]
13. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
14. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.
Ma Y; Dong S; Li X; Kim BYS; Yang Z; Jiang W
Front Oncol; 2020; 10():606906. PubMed ID: 33628730
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives.
Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J
J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599
[TBL] [Abstract][Full Text] [Related]
17. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
Lamichhane TN; Jay SM
Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
[TBL] [Abstract][Full Text] [Related]
18. Engineered Extracellular Vesicles for Cancer Therapy.
Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
[TBL] [Abstract][Full Text] [Related]
19. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
20. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.
Lamichhane TN; Raiker RS; Jay SM
Mol Pharm; 2015 Oct; 12(10):3650-7. PubMed ID: 26376343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
